Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 1271 and 1528 of Human DLC1|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 1% BSA, 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-29784 targets DLC1 in IHC (P) and WB applications and shows reactivity with Human samples.
The PA5-29784 immunogen is recombinant fragment corresponding to a region within amino acids 1271 and 1528 of Human DLC1.
This gene is deleted in the primary tumor of hepatocellular carcinoma. It maps to 8p22-p21.3, a region frequently deleted in solid tumors. It is suggested that this gene is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers. Alternative splicing at this locus results in several transcript variants encoding different isoforms.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
ARHGAP7; deleted in liver cancer 1 protein; deleted in liver cancer 1 variant 2; deleted in liver cancer variant 4; HP; p122-RhoGAP; rho GTPase-activating protein 7; Rho-GTPase-activating protein 7; rho-type GTPase-activating pr; rho-type GTPase-activating protein 7; StAR-related lipid transfer (START) domain containing 12; STARD12; START domain-containing protein 12
ARHGAP7; DLC1; HP; KIAA1723; p122-RhoGAP; STARD12